Secondary Analysis of RTOG 9704 Gemcitabine versus 5-FU in Resectable Pancreatic Cancer
Theodore S. Hong, MD of Massachusetts General Hospital discusses the Secondary Analysis of RTOG 9704 Gemcitabine versus 5-FU in Resectable Pancreatic Cancer at ASCO GI 2017
Author: ASCOGI2017
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
What To Consider When Treating a Newly Diagnosed Stage 4 Pancreatic Cancer Patient
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on considerations when treating a newly diagnosed patient with stage 4 pancreatic cancer at the 2017 Gastrointestin...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Should Resected Pancreatic Cancer Patients Be Offered Adjuvant Therapy
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute discusses whether or not resected pancreatic cancer patients should be offered adjuvant therapy at the 2017 Gastrointestinal Cancers Symp...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Pancreatic cancer: The Lancet: January 24, 2017
John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 25, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts
Is Chemo Brain Real? A Cancer Survivors Take
Is chemo brain real or just an excuse? Pancreatic cancer survivor, Anne Gruzdowich, shares her experience with chemo brain, referring to it as a reality. Chemo brain is a real side effect of chemoth...
Author: patientpower
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Surviving and Staying Strong After a Pancreatic Cancer Diagnosis
How do you survive a pancreatic cancer diagnosis? Meet self-described pedal-to-the-metal woman, Anne Gruzdowich, a wife of 36 years with two children, who learned at the age of 59 that she had pancr...
Author: patientpower
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Pancreatic Cancer Trends for 2017
Davendra Sohal, MD of Cleveland Clinic outlines the Pancreatic Cancer Trends for 2017 from ASCO GI 2017
Author: ASCOGI2017
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Improvement in Systemic Therapies Needed in in Pancreatic Cancer
Davendra Sohal, MD of Cleveland Clinic discusses that Improvement in Systemic Therapies are Needed in in Pancreatic Cancer from ASCO GI 2017
Author: ASCOGI2017
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Results from Internal Expediance Borderline Resectable Pancreas Cancer
Davendra Sohal, MD of Cleveland Clinic presents the Results from Internal Expedience Borderline Resectable Pancreas Cancer at ASCO GI 2017
Author: ASCOGI2017
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Will SWOG S1505 Impact Treatment of Pancreatic Cancer
Davendra Sohal, MD of Cleveland Clinic answers the question Will SWOG S1505 Impact Treatment of Pancreatic Cancer at ASCO GI 2017
Author: ASCOGI2017
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Challenges in Treating Pancreatic Cancer
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the challenges she's faced in treating pancreatic cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, CA.
Author: obr
Added: 01/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2017 Category: Cancer & Oncology Source Type: podcasts
Trial and Drug Development in Pancreatic Cancer
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the upcoming trial and drug development in pancreatic and gastrointestinal cancers at the 2017 Gastrointestinal Cancers Symposium (ASCO...
Author: obr
Added: 01/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2017 Category: Cancer & Oncology Source Type: podcasts
New agents/strategies on the horizon in pancreatic cancer
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Margaret A. Tempero discusses new agents and strategies on the horizon in pancreatic cancer.
Author: imedex
Added: 08/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 5, 2016 Category: Cancer & Oncology Source Type: podcasts
Are we making progress in surgery of the pancreas?
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Massimo Falconi examines whether or not we are making progress in surgery of the pancreas.
Author: imedex
Added: 08/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 5, 2016 Category: Cancer & Oncology Source Type: podcasts
